Skip to main content

An Open label single arm phase I study of the pahramcokinetics and safety of Carfilzomib in subjects with advanced malignancies and varing degrees of hepatic impairment.

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Onyx Pharmaceuticals, Inc

Start Date

December 1, 2013

End Date

February 26, 2018
 

Administered By

Duke Cancer Institute

Awarded By

Onyx Pharmaceuticals, Inc

Start Date

December 1, 2013

End Date

February 26, 2018